Skip to content

Effects of Kinesio Taping Techniques in COPD Patients

Effects of Kinesio Taping Techniques on Pulmonary Parameters and Functional Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04241510
Enrollment
43
Registered
2020-01-27
Start date
2022-04-20
Completion date
2022-10-31
Last updated
2022-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Chronic Obstructive Pulmonary Disease, Mechanical Correction, Facilitation, Thoracic Taping, Kinesio Taping, Respiratory Muscle Strength, Pulmonary Functions, Functional Exercise Capacity

Brief summary

Study will investigate effects of two different kinesio taping techniques on pulmonary parameters of patients with COPD.

Detailed description

Chronic Obstructive Pulmonary Disease (COPD) is an irreversible, progressive, treatable airway disease which causes dyspnea, wheezing, coughing and increased secretions in airways. Thoracic and respiratory mechanics are impaired, respiratory muscle strength and functional exercise capacity is decreased in patients with COPD. As a result dyspnea, limitation in activities of daily living, postural impairments, muscle length-strength relationship changes and increased mechanical loads on respiratory muscles occur. In literature it has been demonstrated that Kinesio Taping have therapeutic effects on respiratory functions and functional exercise capacity in patients with chronic neurological diseases who has additional respiratory impairments. Although there are several studies in literature investigating the effects of facilitation and inhibition taping techniques applied on respiratory muscles in patients with COPD, effects of thoracic and postural mechanical correction techniques as an alternative treatment modality in patients with COPD have not been investigated yet. In present study, effects of thoracic mechanical correction and facilitation taping techniques in patients with COPD will be investigated, and data will be collected for effects of thoracic mechanical correction taping on pulmonary parameters in patients with COPD.

Interventions

DEVICEKinesio Taping

Kinesio Taping is a special taping method developed by Dr. Kenzo Kase in 1973. This technique triggers natural healing responses of human body by activating nervous and circulatory systems. The tapes are thin, latex-free, cotton, porous and anti-allergenic, with equal thickness of epidermis. It has elastic properites which allows the tape to elongate to %55-60 of its original lenght. Tape can be used up to 1 week even after sweating or cleaning with water. There are different application techniques for different purposes. Facilitation technique facilitates muscle contractions and supports muscle function. Mechancial correction technique is used for joint positioning and correcting motion of muscle-joint dynamics.

Sponsors

Muğla Sıtkı Koçman University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Evaluation of patients after taping application will be done by another physiotherapist who does not know the taping techniques and also cannot see the taped area by clothes of patients.

Intervention model description

Prospective, Double-Blinded, Randomized Crossover Study

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Male and female COPD patients aged between 40-80 years * Diagnosed with COPD stage I-II-III-IV according to GOLD 2019 criterias * Able to speak, understand and read Turkish language * Volunteering to participate in study

Exclusion criteria

* Unstable or acutely exacerbated patients with COPD * Alterations in medical treatment in last 6 months * Having comorbidities that affect directly cardiopulmonary system, uncontrolled arterial hypertension, severe congestive heart failure, coronary arterial disease, heart valve disease * Orthopaedic, neurological, psychiatric disease, peripheral/central nervous system diseases, mental retardation, antidepressants usage, metabolic impairments, malignancy * Unable to cooperate for measurement and treatment techniques used in study * Irritation, infection, allergic reaction, scarred burn or open wound around application area * Enrolled in a comprehensive pulmonary rehabilitation program before study * Application of Kinesio Tape to any body region in the past * History of an open heart surgery or other thoracic surgeries

Design outcomes

Primary

MeasureTime frameDescription
Pulmonary Function Test30 minutes after every applicationPulmonary functions will be evaulated in laboratory conditions. Dynamic lung volumes will be measured using standardized spirometric measurement regulations established by ATS/ERS guidelines.
Respiratory Muscle Strength30 minutes after every applicationRespiratory muscle strenght will be measured as Maximum Inspiratory Pressure & Maximum Expiratory Pressure with MicroMPM device. Measuring procedure will be held according to ERS guidelines. Measurements will be interpreted with Black and Hyatt's references.
Functional Exercise Capacity30 minutes after every applicationFunctional exercise capacity will be measured with 6-minute walk test. Cardiovascular paremeters, dyspnea, respiratory rate and fatigue will be evaulated before, during and after the test .
Dyspnea30 minutes after each applicationDyspnea in daily living was evaluated by the Modified Medical Research Council Dyspnea Scale. The scale consists in five statements that describe almost the entire range of dyspnea from none (Grade 0) to almost complete incapacity (Grade 4). Higher scores indicates increased dyspnea perception.

Secondary

MeasureTime frameDescription
Perception of Disease30 minutes after each application.COPD Assesment Test (CAT) will be used to evaulate patients perception of symptoms.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026